Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: Variation by country beyond predictive profile-Reference-Cited by-同舟云学术

Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: Variation by country beyond predictive profile

Published:1993-02 Issue:2 Volume:21 Page:281-286
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Barbash Gabriel I,Modan Michaela,Goldbourt Uri,White Harvey D,Van de Werf Frans

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial

2. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin;Lancet,1990

3. GISSI-2: a factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction;Lancet,1990

4. Adjustment of data without use of multivariate models,1989

5. A review of goodness of fit statistics for use in the development of logistic regression models;Lemeshow;Am J Epidemiol,1982

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commentary;Neurosurgery;2016-09

2. Defining Regions in Multiregional Clinical Trials: An Analytical Approach to Considering Impact of Intrinsic and Extrinsic Factors;Therapeutic Innovation & Regulatory Science;2016-01

3. Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial;EuroIntervention;2013-02

4. Implications of geographical variation on clinical outcomes of cardiovascular trials;American Heart Journal;2012-09

5. Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world;International Journal of Cardiology;2012-03